Literature DB >> 1961717

T lymphocytes inhibit the vascular response to injury.

G K Hansson1, J Holm, S Holm, Z Fotev, H J Hedrich, J Fingerle.   

Abstract

The proliferation of vascular smooth muscle cells is controlled by specific growth factors and cytokines acting in paracrine networks. Macrophage products such as the platelet-derived growth factor and interleukin 1 promote smooth muscle proliferation and are released in the arterial wall during atherosclerosis and repair processes. T lymphocytes are also present in vascular tissue, but their role in vascular growth control in vivo has been unclear. We now demonstrate that rats in which T lymphocytes have been eliminated by a monoclonal antibody develop larger proliferative arterial lesions after balloon-catheter injury. Larger lesions also develop in athymic rnu/rnu rats that lack T lymphocytes, when compared with rnu/+ littermates with normal T-cell levels. Finally, injection of the lymphokine interferon gamma inhibits smooth muscle proliferation and results in smaller lesions compared with controls injected with buffer alone. These results indicate that T lymphocytes modulate smooth muscle proliferation during vascular repair. We propose that T lymphocytes may play an important, immunologically nonspecific role in tissue repair processes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961717      PMCID: PMC52962          DOI: 10.1073/pnas.88.23.10530

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.

Authors:  E W Raines; S K Dower; R Ross
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

2.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization.

Authors:  J N Wilcox; K M Smith; L T Williams; S M Schwartz; D Gordon
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

Review 3.  Immune mechanisms in atherosclerosis.

Authors:  G K Hansson; L Jonasson; P S Seifert; S Stemme
Journal:  Arteriosclerosis       Date:  1989 Sep-Oct

4.  Vascular effects of cyclosporine A in vivo and in vitro.

Authors:  G Ferns; M Reidy; R Ross
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

5.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

6.  Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro.

Authors:  G K Hansson; L Jonasson; J Holm; M M Clowes; A W Clowes
Journal:  Circ Res       Date:  1988-10       Impact factor: 17.367

7.  Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.

Authors:  L Jonasson; J Holm; G K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  Smooth muscle cells express Ia antigens during arterial response to injury.

Authors:  L Jonasson; J Holm; G K Hansson
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

9.  Quantitation of mRNA by the polymerase chain reaction.

Authors:  A M Wang; M V Doyle; D F Mark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.

Authors:  G K Hansson; M Hellstrand; L Rymo; L Rubbia; G Gabbiani
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  34 in total

1.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

Authors:  W Palinski; S Hörkkö; E Miller; U P Steinbrecher; H C Powell; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro.

Authors:  S Caspar-Bauguil; M Saadawi; A Negre-Salvayre; M Thomsen; R Salvayre; H Benoist
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.

Authors:  A Daugherty; E Puré; D Delfel-Butteiger; S Chen; J Leferovich; S E Roselaar; D J Rader
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 4.  Lipoproteins and their functions.

Authors:  A J Habenicht; U Janssen-Timmen; R Ziegler; G Schettler
Journal:  Clin Investig       Date:  1994-09

5.  NADPH oxidase in vascular injury: a new insight about its regulation and role in T cells.

Authors:  Jun-ichi Abe; Chang-Hoon Woo
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

6.  Immunopathological features of rat Staphylococcus aureus arthritis.

Authors:  T Bremell; S Lange; R Holmdahl; C Rydén; G K Hansson; A Tarkowski
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 7.  Neointimal hyperplasia associated with synthetic hemodialysis grafts.

Authors:  Li Li; Christi M Terry; Yan-Ting E Shiu; Alfred K Cheung
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

Review 8.  The expression and functions of toll-like receptors in atherosclerosis.

Authors:  Jennifer E Cole; Ektoras Georgiou; Claudia Monaco
Journal:  Mediators Inflamm       Date:  2010-06-24       Impact factor: 4.711

9.  Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.

Authors:  S Caspar-Bauguil; J Tkaczuk; M J Haure; M Durand; J Alcouffe; M Thomsen; R Salvayre; H Benoist
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

10.  Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions.

Authors:  M D Rekhter; K Zhang; A S Narayanan; S Phan; M A Schork; D Gordon
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.